Scanbio Denmark ApS: Financial statements 2021
CVR: 42107654
Source: annual report 2021, Danish Business Authority
08/02/2021 – 31/12/2021
Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 2,484,644 and a net result of DKK 447,682. Equity in the 2021 report amounted to DKK 487,682. The solvency ratio was 2.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,484,644
- Profit/Loss
- DKK 447,682
- Equity
- DKK 487,682
- Total Assets
- DKK 20,544,187
- Employees
- 3
Official annual report
Find more companies like Scanbio Denmark ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 8, 2021, Kamel Gabriel El Khaloui is registered as director of Scanbio Denmark ApS.
As of October 8, 2021, Karsten Himmelstrup has stepped down as director of Scanbio Denmark ApS.
As of February 8, 2021, Karsten Himmelstrup is registered as director of Scanbio Denmark ApS.
As of February 8, 2021, is registered as an owner of Scanbio Denmark ApS with an ownership share of 100%.
Scanbio Denmark ApS was founded on February 8, 2021.
About Scanbio Denmark ApS
Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity in the 2025 report amounted to DKK 10,249,140.